Skip to main content

Peer Review reports

From: Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials

Original Submission
6 Apr 2016 Submitted Original manuscript
29 Sep 2016 Author responded Author comments - Takashi Shigematsu
25 Apr 2016 Reviewed Reviewer Report - Bjorn Meijers
9 Aug 2016 Reviewed Reviewer Report - Khashayar Sakhaee
14 Aug 2016 Reviewed Reviewer Report - Cheryl Sadowski
Resubmission - Version 2
29 Sep 2016 Submitted Manuscript version 2
20 Nov 2016 Author responded Author comments - Takashi Shigematsu
29 Oct 2016 Reviewed Reviewer Report - Bjorn Meijers
18 Oct 2016 Reviewed Reviewer Report - Khashayar Sakhaee
18 Oct 2016 Reviewed Reviewer Report - Cheryl Sadowski
Resubmission - Version 3
20 Nov 2016 Submitted Manuscript version 3
21 Dec 2016 Author responded Author comments - Takashi Shigematsu
24 Nov 2016 Reviewed Reviewer Report - Bjorn Meijers
7 Dec 2016 Reviewed Reviewer Report - Khashayar Sakhaee
13 Dec 2016 Reviewed Reviewer Report - Cheryl Sadowski
Resubmission - Version 4
21 Dec 2016 Submitted Manuscript version 4
1 Feb 2017 Author responded Author comments - Takashi Shigematsu
21 Jan 2017 Reviewed Reviewer Report - Bjorn Meijers
2 Jan 2017 Reviewed Reviewer Report - Cheryl Sadowski
Resubmission - Version 5
1 Feb 2017 Submitted Manuscript version 5
Publishing
8 Feb 2017 Editorially accepted
15 Feb 2017 Article published 10.1186/s12882-017-0478-9

You can find further information about peer review here.

Back to article page